Donald Lehr - Precigen Chief Legal Officer
| I5X Stock | EUR 0.85 0.07 8.97% |
Executive
Mr. Donald P. Lehr is the Chief Legal Officer of Intrexon Corporationrationration. Prior to joining us, he practiced law with the law firm of Hogan Lovells LLP in Baltimore, Maryland from 2002 to 2009. While at Hogan Lovells, his practice included the representation of privately and publicly held corporations across many industries, including biotechnology, pharmaceuticals, health care, software, technology, and manufacturing. Prior to his time at Hogan Lovells, Mr. Lehr served as a judicial clerk for the Honorable Irma S. Raker of the Court of Appeals of Maryland since 2011.
| Age | 48 |
| Tenure | 13 years |
| Phone | 301 556 9900 |
| Web | https://www.precigen.com |
Donald Lehr Latest Insider Activity
Tracking and analyzing the buying and selling activities of Donald Lehr against Precigen stock is an integral part of due diligence when investing in Precigen. Donald Lehr insider activity provides valuable insight into whether Precigen is net buyers or sellers over its current business cycle. Note, Precigen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Precigen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Donald Lehr over three months ago Acquisition by Donald Lehr of 400000 shares of Precigen at 1.4 subject to Rule 16b-3 | ||
Donald Lehr over six months ago Acquisition by Donald Lehr of 164285 shares of Precigen subject to Rule 16b-3 | ||
Donald Lehr over six months ago Disposition of 164285 shares by Donald Lehr of Precigen subject to Rule 16b-3 |
Precigen Management Efficiency
The company has return on total asset (ROA) of (0.1219) % which means that it has lost $0.1219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5132) %, meaning that it generated substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.51 | |||
| Return On Asset | -0.12 |
Precigen Leadership Team
Elected by the shareholders, the Precigen's board of directors comprises two types of representatives: Precigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precigen. The board's role is to monitor Precigen's management team and ensure that shareholders' interests are well served. Precigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Frank, Independent Director | ||
| Jeffrey Kindler, Independent Director | ||
| Rob Russell, VP HR | ||
| Randal Kirk, Chairman of the Board, Chief Executive Officer | ||
| Rick Sterling, Chief Financial Officer | ||
| Cesar Alvarez, Independent Director | ||
| Donald Lehr, Chief Legal Officer | ||
| Vinita Gupta, Independent Director | ||
| Rutul Shah, Chief Officer | ||
| Jeffrey Perez, Senior Vice President — Intellectual Property Affairs | ||
| Randal JD, Ex Chairman | ||
| Helen MPH, CEO Pres | ||
| Steven Harasym, VP Relations | ||
| Fred Hassan, Independent Director | ||
| James Turley, Independent Director | ||
| Helen Sabzevari, President, Chief Executive Officer, President - Precigen, Inc. | ||
| Harry Thomasian, Chief Officer | ||
| Marie Rossi, VP Communications | ||
| Dean Mitchell, Independent Director | ||
| Thomas Reed, Founder, Chief Science Officer | ||
| Robert Shapiro, Lead Independent Director |
Precigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.51 | |||
| Return On Asset | -0.12 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | (0.52) % | |||
| Current Valuation | 326.26 M | |||
| Shares Outstanding | 251.01 M | |||
| Shares Owned By Insiders | 10.09 % | |||
| Shares Owned By Institutions | 55.62 % | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 2.70 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Precigen Stock
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Precigen Stock please use our How to Invest in Precigen guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.